Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | TP53 | P04637 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | TNKS | O95271 | 3/20 | 1.00 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.87 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.87 |
| ▸ | HPGD | P15428 | 5/20 | 0.87 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.87 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.87 |
| ▸ | MAOB | P27338 | 8/20 | 0.81 |
| ▸ | NPC1 | O15118 | 4/20 | 0.80 |
| ▸ | RAB9A | P51151 | 4/20 | 0.80 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.80 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.80 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30120666 | 1.00 | CYP3A4 (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL30266579 | 0.93 | CYP3A4 (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL312254 | 0.93 | CYP3A4 (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| 4,7-Dimethoxyflavone SCHEMBL3470601 | 0.90 | MAOB (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL31675989 | 0.89 | MAPT (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL490928 | 0.89 | MAPT (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL4404220 | 0.89 | CYP3A4 (0.80) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL9663461 | 0.87 | CSNK2A2 (0.87) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL31167385 | 0.87 | CYP3A4 (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 | |
| SCHEMBL157723 | 0.87 | CYP3A4 (1.00) | CYP3A4TP53MEN1KMT2ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250161459-A1 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | ADARX PHARMACEUTICALS, INC. (US) | 2025-05-22 | — | — | US | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025038960-A1 | OLIGONUCLEOTIDES CONTAINING A LIGAND AT AN INTERNAL POSITION | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | claimed |
| WO-2024220449-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | ASKLEPIOS BIOPHARMACEUTICAL, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| US-20110223256-A1 | Method For Stabilizing Flavonoid Aqueous Dispersion | STOKELY-VAN CAMP, INC. (US) | 2011-09-15 | — | — | US | claimed |
| WO-2011112386-A1 | METHOD FOR STABILIZING WATER INSOLUBLE BIOACTIVE COMPOUND AQUEOUS DISPERSIONS | STOKELY-VAN CAMP, INC. (US) | 2011-09-15 | — | — | WO | claimed |
| US-7767238-B2 | Beverage composition and method of preventing degradation of vitamins in beverages | PEPSICO, INC. (US) | 2010-08-03 | — | — | US | claimed |
| WO-2010038153-A1 | USE OF SOX TRANSCRIPTION FACTOR ACTI\\ATORS FOR STIMULATING CHONDROGENESIS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2010-04-08 | — | — | WO | claimed |
| CN-101069563-A | Beverage composition and method for preventing degradation of vitamins in beverages | PEPSICO INC (US) | 2007-11-14 | — | — | CN | claimed |
| US-20070110851-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PEPSICO, INC. | 2007-05-17 | — | — | US | claimed |
| EP-1782701-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PepsiCo, Inc. (US) | 2007-05-09 | — | — | EP | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | claimed |
| EP-0124393-A1 | Hair dyeing composition and process | ALBAN MULLER INTERNATIONAL, S.A.R.L. (FR) | 1984-11-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | CYP3A4 3571/4885TP53 297/4885MEN1 1711/4885 |
| US-20250161459-A1 | TRKB LIGAND CONJUGATED COMPOUNDS AND USES THEREOF | NTRK2, NTRK1, BDNF | CYP3A4 4808/4885TP53 2232/4885MEN1 4051/4885 |
| US-20110223256-A1 | Method For Stabilizing Flavonoid Aqueous Dispersion | MLN, NSF, CEL | CYP3A4 2694/4885TP53 868/4885MEN1 1705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.